|
|
- NEWSLETTERS
- MOBILE APPS
-
ADD TIME NEWS
How to Beat AIDS?
A 3D x-ray image shows an antibody (the green ribbon) in contact with a critical target (yellow) for vaccine developers.
While b12 is a rare antibody, occuring in only a very few individuals, what it does to this particularly vulnerable protein in the HIV virus has now been documented in great detail in the new study. The b12 antibody thus provides a key to scientists: its behavior will give them a precise roadmap on which to develop potential vaccines that would replicate b12's actions. One other advantage of b12 and its target protein (which is called HIV gp120): while the HIV virus is known to mutate over and over again, the HIV gp120 protein is stable throughout the existing strains of the virus. Thus, a vaccine developed with b12 as a template could potentially be used against all known variants of HIV. Now, the race is on to create and then test those vaccines. The otherworldly bouquet may produce some very earthly benefits.
Most Popular »
- Jenny Sanford: The Savviest Spurned Woman in History
- America's Most Wanted Teenage Bandit
- Church Group Attacks Christmas Commercialism
- Rattled by Iran, Arab Regimes Draw Closer
- Israel vs. Hizballah: Drumbeats of War
- How to Rule India: Break It Into More Pieces?
- Corliss Appraises Avatar: A World of Wonder
- Citi's TARP Repayment: The Downside for a Troubled Bank
- A Mounting Suicide Rate Prompts an Army Response
- Ayatullah Khomeini Returns to Haunt Iranian Politics
- Church Group Attacks Christmas Commercialism
- America's Most Wanted Teenage Bandit
- A Mounting Suicide Rate Prompts an Army Response
- How to Rule India: Break It Into More Pieces?
- Citi's TARP Repayment: The Downside for a Troubled Bank
- Jenny Sanford: The Savviest Spurned Woman in History
- In Hershey's Possible Cadbury Bid, a School's Fate
- Citi's Dubai Mistake: A Sign of More Bad Things to Come?
- Rattled by Iran, Arab Regimes Draw Closer
- Corliss Appraises Avatar: A World of Wonder





RSS